AI pharmaceutical finally extends to skincare and anti-aging. Yingxi Intelligent has crossed over from oncology to skin management, with an LLPS platform plus small molecule degradation. Is the ultimate goal of scientific skincare clinical implementation?

View Original
CoinNetwork
CoinWorld News, Yingxi Intelligent and Wuxi Yituo Medical Technology Co., Ltd. (referred to as "Yituo Medical") have signed an expanded strategic cooperation agreement.
Based on their existing collaboration on the development of protein degradation small molecule candidate drugs targeting tumor biomarkers, the two parties will further expand the scope of indications, focusing on AI-enabled innovative drug development in the fields of skin management and skin anti-aging.
Relying on an AI-driven biological platform and a specialized LLPS research platform, they will promote original small molecule drugs for scientific skincare and skin anti-aging from basic research to accelerate clinical application and industrialization.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned